# Hyperemic Efficacy of IV Adenosine in HFrEF

> **NCT03235700** · NA · UNKNOWN · sponsor: **Sejong General Hospital** · enrollment: 125 (estimated)

## Conditions studied

- Heart Failure With Reduced Ejection Fraction
- Coronary Artery Disease

## Interventions

- **OTHER:** Maximal hyperemia with adenosine followed by nicorandil
- **OTHER:** Maximal hyperemia with nicorandil followed by adenosine

## Key facts

- **NCT ID:** NCT03235700
- **Lead sponsor:** Sejong General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-03-01
- **Primary completion:** 2020-02-28
- **Final completion:** 2020-02-28
- **Target enrollment:** 125 (ESTIMATED)
- **Last updated:** 2017-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03235700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03235700, "Hyperemic Efficacy of IV Adenosine in HFrEF". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03235700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*